SUBSEQUENT EVENTS	3 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 3 - SUBSEQUENT EVENTS Completion of underwritten U.S. public offering On April 13, 2023, the Company completed an underwritten U.S. public offering under which the Company received gross proceeds of approximately $10,000 thousand for issuance of (i) 5,376,472 shares of common stock and (ii) 1,976,470 pre-funded warrants at a price to the public of $1.36 per share. The pre-funded warrants are exercisable for the same number of shares of common stock and may be exercised at any time until exercised in full at an exercise price of $0.001. Upon satisfaction of customary closing conditions, the closing date of the public offering was April 17, 2023 (the “Closing Date”). Since the Company receives substantially all of the pre-funded warrant’s proceeds upfront (without any conditions) as part of the pre-funded warrant’s purchase price and in return the Company is obligated to issue fixed number of shares of common stock to the holders. Thus, pre-funded warrants will be accounted for and classified as additional paid-in capital as part of the Company’s stockholders’ equity. The total incremental and direct issuance costs amounted to $1,270 thousand. These expenses will be deducted from additional paid-in capital as they should be allocated to shares of common stock and pre-funded warrants. On November 22, 2022, Nasdaq provided notice that pursuant to Nasdaq Listing Rule 5550(b)(1), the Company is required to maintain a minimum of $2,500 thousand in stockholders’ equity. In addition, the Company does not meet the alternatives of market value of listed securities or net income from continuing operations. Upon closing of underwritten U.S. public offering, the Company meets the requirement under the above rule as on a pro forma basis, with giving effect to approximately $8,730 thousand net raise, the balance sheet as of March 31, 2023 has assets of approximately $9,777 thousand and shareholders’ equity of $8,741 thousand.

SUBSEQUENT EVENTS

3 Months Ended

Mar. 31, 2023

NOTE 3 - SUBSEQUENT EVENTS

Completion of underwritten U.S. public offering

On April 13, 2023, the Company completed an underwritten U.S. public offering under which the Company received gross proceeds of approximately $10,000 thousand for issuance of (i) 5,376,472 shares of common stock and (ii) 1,976,470 pre-funded warrants at a price to the public of $1.36 per share. The pre-funded warrants are exercisable for the same number of shares of common stock and may be exercised at any time until exercised in full at an exercise price of $0.001.

Upon satisfaction of customary closing conditions, the closing date of the public offering was April 17, 2023 (the “Closing Date”).

Since the Company receives substantially all of the pre-funded warrant’s proceeds upfront (without any conditions) as part of the pre-funded warrant’s purchase price and in return the Company is obligated to issue fixed number of shares of common stock to the holders. Thus, pre-funded warrants will be accounted for and classified as additional paid-in capital as part of the Company’s stockholders’ equity.

The total incremental and direct issuance costs amounted to $1,270 thousand. These expenses will be deducted from additional paid-in capital as they should be allocated to shares of common stock and pre-funded warrants.

On November 22, 2022, Nasdaq provided notice that pursuant to Nasdaq Listing Rule 5550(b)(1), the Company is required to maintain a minimum of $2,500 thousand in stockholders’ equity. In addition, the Company does not meet the alternatives of market value of listed securities or net income from continuing operations. Upon closing of underwritten U.S. public offering, the Company meets the requirement under the above rule as on a pro forma basis, with giving effect to approximately $8,730 thousand net raise, the balance sheet as of March 31, 2023 has assets of approximately $9,777 thousand and shareholders’ equity of $8,741 thousand.